Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2024 Results on October 17, 2024
07 Octobre 2024 - 2:00PM
Business Wire
Elevance Health (NYSE: ELV) will release third quarter
2024 financial results on October 17, 2024, at 6:00 a.m. Eastern
Daylight Time (“EDT”). Management will review these results and its
outlook during a conference call at 8:30 a.m. EDT that same
morning. The conference call should be accessed at least 15 minutes
prior to its start with the following numbers:
- 888-947-9963 – Access Code - 3972058 (Domestic)
- 312-470-0178 – Access Code - 3972058
(International)
- 866-510-4837 – No Access Code (Domestic Replay)
- 203-369-1943 – No Access Code (International Replay)
The replay will be available from 11:30 a.m. EDT on October 17,
2024, until the end of the day on November 16, 2024. The call will
also be available through a live webcast at
www.elevancehealth.com under the “Investors” link. You may
also access the webcast here. A webcast replay will be
available following the call.
About Elevance Health, Inc.
Elevance Health is a lifetime, trusted health partner whose
purpose is to improve the health of humanity. The company supports
consumers, families, and communities across the entire healthcare
journey – connecting them to the care, support, and resources they
need to lead better lives. Elevance Health’s companies serve over
113 million consumers through a diverse portfolio of
industry-leading medical, pharmacy, behavioral, clinical, and
complex care solutions. For more information, please visit
www.elevancehealth.com or follow us @ElevanceHealth
on X and Elevance Health on LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241006390302/en/
Investor Relations: Stephen Tanal
Investor.Relations@elevancehealth.com
Media Relations: Leslie Porras
Leslie.Porras@elevancehealth.com
Elevance Health (NYSE:ELV)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024
Elevance Health (NYSE:ELV)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024